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Foreword
Professor Duncan Q.M. Craig FRPharmS
Director, UCL School of Pharmacy
United Kingdom
I am delighted and honoured to provide a foreword for this publication, which 
outlines the outcomes of the ‘Students as Global Citizens’ project, run in collaboration 
with our partners in Institute of Education (University of London), the UCL Institute 
for Global Health, the Royal Veterinary College and the London International 
Development Centre. 
The changing nature of global healthcare, communication and education now 
require us to look closely at ourselves and the manner in which we are preparing 
students worldwide for these new challenges and opportunities.  As a well-
established educational institution, we have a particular responsibility to begin such 
considerations close to home and I am very pleased to report that the work outlined 
in this project has had a significant influence on our own course design as we move 
forward into our new MPharm degree. We hope that other Schools will find it equally 
informative and stimulating and we look forward to an era in which we place much 
more emphasis on producing rounded and considerate individuals who will lead the 
profession forward to the maximum benefit of public health worldwide.
Our profound thanks go to the UK Department for International Development who 
funded the project and we look forward to continuing to develop our thinking and 
our courses, informed by these highly topical and vitally important considerations.
Professor Tina Penick Brock BPharm, MSc, EdD
Professor of Clinical Pharmacy, Associate Dean for Teaching & Learning
University of California, San Francisco USA
Almost 25 years ago, as a new pharmacy graduate in the United States, I had only 
minimal understanding of the key issues associated with global health and even 
less appreciation for the tremendous impact these ultimately would have on my 
life – professionally and personally. Now, placing these in the context of a career that 
spans a variety of settings and locales, it is clear to me that purposeful exposure to 
global and development issues is critical for creating a pharmaceutical workforce with 
the knowledge, skills and attitudes to address the health needs of a society that has 
evolved into a ‘global village’.
In this report, the globally-engaged authoring team suggests that pharmacists must 
take responsibility for increasing access to and improving use of medicines in both 
locally globalized environments such as the United Kingdom and globally localized 
environments such as those further afield.  Citing findings from the ‘Students as Global 
Citizens’ project and highlighting perspectives from educators, researchers, and 
students, the authors describe ways that this can be taught intentionally – from surface 
explorations to deep dives, by connecting across health professions, and inclusive of 
undergraduate and post-graduate instructional systems.
The next generation of healthcare professionals in our global village will surely benefit 
from the chance to work toward the proposed global pharmacy learning outcomes!

1This work has led to the development of a range 
of new teaching and learning activities within 
the UCL School of Pharmacy, as well as a draft 
set of Global Pharmacy Learning Outcomes. This 
report outlines these initiatives and is intended 
to generate further debate and dialogue 
regarding teaching and learning about global 
health concerns within UK schools of pharmacy 
and higher education institutions, as well as the 
pharmacy profession more widely. The report also 
aims to encourage pharmacy students to recognise 
the importance and relevance of global issues to 
their education and professional development and 
to understand the ways in which global issues will 
impact their future careers.
The challenge for schools of pharmacy, as for 
other higher education institutions, is how to 
best prepare our students so that they develop 
an appreciation of the importance of global 
perspectives in health and medicines use, 
acquire the skills and aspirations to address new 
challenges, and recognise the career opportunities 
that this presents.
This publication reflects upon the experiences 
of the ‘Students as Global Citizens’ project 
from a pharmacy perspective. The project was 
a collaboration between the UCL School of 
Pharmacy, the Institute of Education (University 
of London), the UCL Institute for Global Health, 
the Royal Veterinary College and the London 
International Development Centre, and was 
funded by the UK Department for International 
Development. The main aim of the project was 
to develop and evaluate methods to integrate 
teaching and learning about global and 
development issues into undergraduate curricula 
in pharmacy, medicine and veterinary medicine.
Globalisation can facilitate improvements in health through the speed and ease 
of shared information, advances in health care delivery and health policy, and 
the enhanced pace of discovery through international research collaborations. 
However, there are associated potential risks to health such as the spread 
of communicable diseases and antibiotic-resistance. Current international 
priorities in the development, supply and use of medicines reflect the influence 
of globalisation. This is relevant to all aspects of contemporary pharmacy, and 
means that graduates are increasingly working in a globalised profession.
Executive Summary
2Introduction
The processes of globalisation have led to an 
increasingly interconnected world, with both 
benefits and costs for health. The speed and ease 
of shared information, advancements to health 
care delivery and health policy, and the increased 
pace of discovery through international research 
collaborations, can all facilitate improvements to 
health. At the same time, a significant increase 
in international travel has assisted the spread of 
communicable disease, such as the 2003 epidemic 
of severe acute respiratory syndrome (SARS) and 
the growth of antibiotic-resistant Pneumococcus. 
Worldwide, non-communicable diseases which 
until relatively recently were principally associated 
with the most affluent regions have become 
a major concern across the globe. A range of 
particular problems in medicines and health, 
such as counterfeit and poor-quality antimalarial 
drugs, gaps in funding and immunisation for polio 
eradication, the expected increase in global cancer 
incidence rates, and drugs for neglected tropical 
diseases such as rabies, leprosy, Yaws disease and 
dracunculiasis, also highlight the importance of 
global perspectives on health. A lack of skilled 
professionals, in particular net migration from 
‘developing’ to ‘developed’ countries is also 
recognised as a barrier to the delivery of effective 
health care around the world. Health priorities, for 
which the supply and use of medicines is often 
central, must increasingly be viewed from a global 
perspective.
The importance of global perspectives is 
recognised by both the UK government 
and international health organisations. The 
International Pharmaceutical Federation (FIP), in 
collaboration with the World Health  Organization 
(WHO) and United Nations Educational, Scientific 
and Cultural Organization (UNESCO), has formed 
a Pharmacy Education Taskforce1, which promotes 
international collaboration in supporting, 
developing and strengthening pharmacy 
education worldwide. The Board of Pharmaceutical 
Sciences (BPS) of FIP similarly recognises the
1 See www.fip.org/education
importance of a global context for the future of 
the pharmaceutical sciences, acknowledging that 
educational programmes will need to reflect rapid 
changes in, and application of, new knowledge, as 
well as emerging issues of global concern2.
Pharmacy student bodies further endorse the 
need for a global perspective. Membership of 
the British Pharmaceutical Students’ Association 
(BPSA) ensures automatic membership of the 
European Pharmaceutical Students’ Association 
(EPSA) and the International Pharmaceutical 
Students’ Federation (IPSF). The EPSA runs a 
number of schemes to encourage the mobility 
of their members, with the aim of enhancing 
cooperation between EPSA member countries. The 
IPSF also promotes student mobility, providing 
financial assistance through its Development 
Fund. Last year, the ‘Student Declaration on the 
Future of Pharmacists’ document produced by the 
EPSA and the IPSF was signed at the Centennial 
Congress of the FIP (see EPSA & IPSF 2012). In this 
declaration, the student authors make it very clear 
that pharmacists have an international role to play, 
for example, in crisis situations, in improving the 
access to medicines and health in impoverished 
areas and isolated populations, in solidarity work 
related to the support of health and social causes, 
in Non-Governmental Organisation (NGOs), in 
increasing the development of medicines for 
rare diseases and those affecting vulnerable 
populations, and in assessing the environmental 
impacts of research.
It was in the context of the challenges that 
globalisation presents for the higher education 
of health professionals that the UK Department 
for International Development (DFID) funded a 
3-year research and development project called 
‘Students as Global Citizens’ beginning in 2009. It 
was a collaboration between the UCL School of 
Pharmacy, the Institute of Education (University of 
London), the UCL Institute for Global Health, the 
Royal Veterinary College and the London
2 See www.fip.org/pharmaceutical_sciences 
3International Development Centre. The main 
aim of the project was to develop and evaluate 
methods to integrate teaching and learning about 
global and development issues into undergraduate 
curricula in pharmacy, medicine and veterinary 
science.
The work of the project led to the development 
of a range of new teaching and learning activities 
within UCL School of Pharmacy, as well as a draft 
set of Global Pharmacy Learning Outcomes (see 
page 20). This report outlines these initiatives and 
aims to generate further debate and dialogue 
regarding teaching and learning about global 
health concerns within UK schools of pharmacy 
and higher education institutions, as well as the 
pharmacy profession more widely3. The report is 
also intended to encourage pharmacy students to 
recognise the importance and relevance of global 
issues to their education, professional development 
and future careers.
3 Discussion of the project’s work with medicine and 
veterinary medicine can be found in Willott et al (2012) 
and Maud et al (2012).
The Patient – From a Global Perspective1
Consider the case of a 40 year-old woman who has recently been diagnosed with tuberculosis (TB). 
A migrant from Pakistan, she is currently living in cramped conditions in east London. Examining this 
patient’s situation from a purely clinical perspective, one might argue that it is caused by the bacterium 
Mycobacterium tuberculosis, which interacts with the body at a cellular level to produce the symptoms 
of TB. The diagnosis indicates a particular kind of treatment, normally a long course of antibiotics. 
The clinical perspective might also look at the living conditions that led to TB being prevalent in the 
patient’s environment, and consider whether this could have an impact on successful treatment.
A global perspective on this patient would be significantly different. First it might ask whether the 
patient is representative of broader trends in TB prevalence by gender, ethnicity and social class. When 
did she arrive in the UK? What circumstances led to her living in cramped, unhygienic conditions that 
led to her acquiring TB? This could initiate a discussion of the relative affluence or poverty of ethnic 
minority groups in different parts of the UK, which could lead to a further discussion of rising levels 
of social and economic inequality. It might examine recent changes to housing benefit laws that 
have forced poor families in London to find very cheap accommodation and has led to a surge in the 
numbers of people living in cramped, unhealthy conditions. It could lead to further discussion of the 
nature of poverty itself and its meanings for those experiencing it.
This perspective has significant implications for the treatment and advice that a pharmacist would 
give to this patient. For instance, given these circumstances, what factors may influence adherence to 
a prescribed drug treatment plan and successful completion of the course of treatment? Furthermore, 
what other determinants might impact on this (e.g. language, access to medication, understanding of 
instructions regarding timing and dosage of drugs)? Are there any particular health beliefs that could 
impact on treatment (e.g. previous experiences of using antibiotics, traditional medicines, diverse 
understandings of health and well-being)? Lastly, are there any cultural issues that have influenced 
her situation? Is the patient relying particularly on her husband, children or broader community 
for support with healthcare, including translation? Has this influenced her attitude to seeking care? 
Looking more deeply at this question may involve gaining a greater understanding of Pakistani 
immigrant communities in the UK, or whether there are social or cultural issues preventing the woman 
accessing care, or not having a positive experience when she does access it.
1 This text borrows from a similar case study in Willott et al (2012: 7).
4The nature of contemporary pharmacy means 
that all graduates are de facto working in a highly 
globalised profession. In the UK, the roles most 
commonly undertaken by pharmacy graduates are 
those in community and hospital practice, with a 
smaller proportion pursuing a career in academia 
or the pharmaceutical industry. Pharmacists in 
the UK, and elsewhere, are likely to encounter 
increasingly diverse patient populations. They will 
also be involved in the management of diseases 
that have generally been associated with other 
regions but now have increased prevalence in the 
UK (e.g. malaria, tuberculosis).
Pharmacists also engage with and are part of 
the international pharmaceutical industry and 
supply chains. They encounter problems such 
as resistance to existing drugs or recreational 
drugs becoming drugs of abuse, which highlight 
the complex issues of international regulation 
and global markets. Medicines supplied through 
unregistered online pharmacies, online advertising 
of prescription drugs, direct-to-consumer websites, 
What is Global Pharmacy?
and the distribution of SSFFC (substandard and 
spurious, falsely-labelled, falsified or counterfeit) 
medicines present further challenges. Thus, global 
perspectives are necessary for the profession to 
develop and maintain effective channels for the 
supply, and safe and effective use of medicines.
The work that pharmacists undertake in diverse 
settings provides a different range of challenges. 
These might include supporting the appropriate 
treatment and management of locally prevalent 
diseases, interacting with different health care 
systems, responding to medicines counterfeiting 
and the use of traditional medicines, and the 
development of new drugs and drug delivery 
systems to address specific or regional health 
needs. An international dimension is therefore 
increasingly pertinent to all aspects of pharmacy 
and medicines: discovery, development, 
formulation and use of medicines, health care 
systems and health priorities; and the roles of 
health professions including pharmacy.
5Pharmacists, traditional medicines and 
‘medicines of the shop’ 
Professor Michael Heinrich, UCL School 
of Pharmacy
People in the UK and practically all other 
countries utilise a wide range of foods and 
medicines with acclaimed therapeutic 
benefits. Often coming from local and 
traditional knowledge many of these 
products have become global commodities 
with new products from all corners of the 
world entering the world’s markets on a 
regular basis. Such products are likely to be 
the latest (now often internet-driven) hypes 
in the market of globalised health-related 
commodities. 
In the context of medicines, pharmacists will be among the first to know what patients may be using 
in addition to prescribed medicines. They are also able to offer advice on what changes to a person’s 
lifestyle (including diet and the use of medicinal products) may help in managing chronic, and other, 
e.g. ageing-related disorders. Again many of these products are derived from local knowledge which 
has gone global. In addition, the common use of herbal medicines and other products in immigrant 
communities is now widely recognised, but still known only to a limited extent and again pharmacists 
need to engage with it. 
However, there is a much larger challenge for pharmacists. A huge share of the world’s population 
has no or very limited access to adequate levels of healthcare and medicines. For obvious reasons, 
in large parts of Africa, Asia, and the Americas, local and traditional medical practices and (often) 
herbal medicines are the first choice. ‘Medicines of the shop’ on the other hand, are what the name 
indicates – unlicensed or licensed products sold in general shops or by ambulant vendors, often with 
inappropriate or even outrageously wrong therapeutic claims and, of course, without adequate advice 
and a lack of quality assurance. Counterfeit medicines (including herbal medicines) are just one of the 
many problems linked to this.
Pharmacists are global citizens and face challenges and opportunities in engaging with these diverse 
responsibilities associated in essence with the widespread use of what are often called ‘natural’ 
medicines. 
6The role of the global pharmacist in 
today’s international pharmaceutical 
industry 
Professor Nigel Ratcliffe, Head, 
School of Pharmacy, Keele University, 
Staffordshire, UK
The Pharmacist has always been a well-
equipped individual and a valuable recruit 
for the Pharmaceutical industry. A key 
contribution they make and key leaders 
they can become. Long this must continue. 
What are the challenges that the industry 
faces?
 The challenges are many, let’s explore a 
few.
Who is prepared to pay for new medicines and what are they prepared to pay for? There is no doubt 
that a product now must without doubt have a major point of differentiation from what is currently 
available. Not just what is generically available but also differentiated from the first in class. The best 
illustration here is the Statin class. No doubt the incremental benefits of the 2nd, 3rd and 4th in class 
were clearly understood but the impact of generic simvastatin on the market was unprecedented. No 
longer may the search for best in class be the rationale for entering or remaining in an area of research 
science. First in class is today more important. This means that the stakes are even higher and the 
race to be first more important than before. The risk for big pharma of setting up a research foothold 
and being ‘pipped to the post’ is significant. The first in class may be reimbursed but the subsequent 
molecule may not. So the large companies are focusing on assessing and acquiring, through a 
variety of creative deal structures, science and products through externalisation i.e. the licensing in 
or acquisition of science. Risk share agreements, co-development, co-marketing are more the vogue 
today than the investment in multiple expensive research targets. 
What does this mean for the Pharmacist today that enters industry? They need to be business savvy, 
they need to be able to spot opportunity, assess opportunity, and understand the market and unmet 
medical need and they need to act fast and decisively. What better all-round individual is there than 
the pharmacist to understand and adapt to serve the industry. The opportunities may also not be 
on your doorstep. In today’s world we have to have a global medicine. All pharmacodynamic and 
pharmacokinetic differences must be understood. In today’s small electronic world the global pull for 
an innovative first in class medicine will be immediate. No longer is a medicine available for a period of 
time in the home market and then other markets approached. Today’s pharmaceutical developments 
have to be global. Today’s pharmacists must emerge trained with a global perspective and must 
approach product development asking what they would want to know to be assured of a product’s 
safety for all potential recipients. We also need pragmatic leaders and those who are prepared to lead 
objectively, to communicate well with the societies and governments served or the costs and delays 
incurred will reduce the number and speed of delivery of the remaining opportunities to patients.
So moving forward, the  Pharmacist must emerge from University with a global awareness, they must 
have finely attuned communication skills but it remains crucial that they maintain their core proficiency 
in science. Science is their foundation, but those who can emerge with some insight into the global 
environment and business that is operating will be of high value.
7Medicines’ counterfeiting and the role 
of pharmacists in preventing harm to 
global public health 
Professor David Taylor, UCL School of 
Pharmacy
Medicines’ counterfeiting is, because it is 
widely seen as a potential threat to every 
medicines taker, a highly newsworthy 
‘story’, which is often reported in dramatic 
language. This modern reality builds on 
the fact that the quality and authenticity 
of medicines has been a cause for public 
concern throughout history. Even when 
populations were (as several billion 
individuals are in large part still today) 
reliant on herbal and other ‘natural’ 
treatments for treating sicknesses, 
there were dangers that medicinal plants would be misidentified by well-intended individuals, or 
deliberately misrepresented by others intent on fraud. In the 17th Century, for instance, widespread 
adulteration for a period undermined public confidence in the efficacy of Chinona bark (the natural 
source of quinine) as a treatment for malaria, which was then prevalent in many parts of Europe. The 
available evidence indicates that in today’s world many more people are killed or otherwise harmed 
by a lack of access to health care professionals and appropriate, good quality, pharmaceuticals than 
by falsified medicines, defined as illegally made drugs that are dishonestly sold as products supplied 
by legitimate manufacturers. However, even though some estimates of the extent of medicines 
counterfeiting (such as claims that ’10 per cent of the world’s medicines by value are falsified’) have on 
occasions been incorrectly attributed to the WHO and are almost certainly exaggerations, there is no 
doubt that hazards to the public’s health exist. Even if in reality only 1 per cent by value of the world’s 
medicines is supplied by counterfeiters who evade regulatory controls designed to assure product 
safety and effectiveness, this endangers millions of people.
Populations living in economically advantaged countries and regions such as the United States, 
Europe and Japan are in the main well protected. Yet even in these settings untoward incidents 
occur. In America, for example, there have been recent cases of falsified versions of drugs such as 
Avastin (made by Roche, and primarily used in cancer care) and Adderall (an ADHD treatment from 
the major generic manufacturer Teva) being supplied via legitimate health care providers, as well as 
via unregulated internet sources.  By contrast in poorer parts of the world like sub Saharan Africa and 
large areas of south eastern Asia the risks associated with medicines falsification are greater. There 
is robust evidence that in the order of a third of the anti-malaria medicines supplied to vulnerable 
communities have in the recent past been falsified, and that this leads to not only avoidable deaths 
but in some circumstances increased drug resistance.  Such problems will tend to increase in both 
low and middle income national settings if public expectations and demands for treatment rise faster 
than governments’ abilities and/or willingness to provide affordable universal access to care, and as 
technologies like those needed to produce good quality fake pharmaceutical packaging and deliver 
medicines via the internet continue to improve. Effective action to protect the global public’s health 
needs to take place at a variety of levels, from constructive co-operation between governments 
through to diligence and integrity amongst individual pharmacists and medicine purchasers and users.
8Research conducted as part of the project at UCL 
School of Pharmacy identified a desire from both 
staff and students to embed global issues more 
formally within the MPharm curriculum. It also 
highlighted further questions:
• What global issues are already being 
included within the current MPharm 
curriculum, and what kinds of teaching 
and learning approaches are being used 
(e.g. lectures, workshops, problem-based 
learning)?
• How do staff at the School perceive the 
relevance of global issues to pharmacy 
education and practice?
• How do students at the School perceive 
the relevance of global issues to pharmacy 
education and practice?
The project team conducted a range of activities 
to explore these questions, including a review 
of the current MPharm curriculum, surveys and 
interviews with staff and students, and piloting 
several new teaching and learning activities. The 
findings are discussed below.
Global issues already included within 
the MPharm curriculum
A review of MPharm curriculum (2011-2012) 
documents and interviews with staff identified a 
number of existing opportunities for students to 
learn about global health topics. Global pharmacy 
issues are introduced to all MPharm students in 
the early years of study and further developed 
throughout the 4-year degree programme in 
diverse contexts, such as:
• Infectious diseases from a global 
perspective
• Impact of global travel on the spread of 
infectious diseases
• Global warming and loss of biodiversity
• Drugs of abuse
• Understanding the roles and activities 
of international organisations (WHO and 
UNICEF)
• Specific diseases such as malaria, 
elephantiasis and leishmaniasis
• Traditional and herbal medicines
• Clinical trials
• International patent laws
• Mental health and illness in diverse cultural 
settings 
• Demographic and epidemiological 
transitions, and their social and economic 
impacts
• Inequalities in health and the extent to 
which they might be reduced, nationally 
and internationally
• Aspects of cultural diversity in the UK in 
terms of medicine-taking and access to 
healthcare
In addition, Global Pharmacy is the main topic of 
study in a dedicated optional module for final year 
MPharm students. Approximately 30 students take 
the module ‘Health care, medicines and pharmacy 
in developing countries’ every year. It provides 
an opportunity for students to examine a wide 
range of factors that affect health and medicines 
use in low and middle-income settings and to 
compare these with those found in higher income 
nations including the UK. Topics include patterns 
of mortality and morbidity, important diseases 
and health care needs in developing countries; 
health care systems and provision in different 
parts of the world and the place of pharmacy 
services; pluralism in health care, especially where 
‘western’ and different forms of ‘traditional’ care 
and medicines use operate side-by-side; social, 
economic, environmental and educational factors 
which influence access to, and use of medicines; 
health and drugs policies, regulation and role of 
WHO, other NGOs and pharmaceutical industry; 
the context of culture: health beliefs, self-
medication and the use of medicines in different 
cultures.
The majority of teaching staff (32/50) include 
global or development issues within their teaching, 
although to varying degrees. Delivery of material 
is often through discussion of international 
Developing a Global Pharmacy Curriculum at 
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9perspectives in lectures and tutorials, with staff 
both formally and less formally drawing on their 
own international experiences. Collaboration 
with community projects (e.g. the Green Light 
Pharmacy in London), and presentations by guest 
speakers with particular experience and expertise 
are further examples. A few staff explore global 
topics in more detail as part of MPharm research 
projects, group discussions or assignments. 
However, in most cases, global health receives only 
a brief mention in relation to specific areas of study 
(e.g. disease prevalence or differences in patterns 
of medicines use in different parts of the world). 
Pharmacists specialising in the care of  
older people 
Dr. Mine Orlu Gul 
Department of Pharmaceutics, UCL 
School of Pharmacy
Life expectancy in low-income countries 
is increasing in a similar manner to that 
in many  European countries. Over 60% 
of the world`s older population currently 
live in China and India. However, despite 
the changing demography, specialist 
medical services for older people in less 
developed countries are inadequate. The 
number of geriatric pharmacists is limited 
to providing healthcare to older patients 
with impairments and specific needs. Older 
patients are often prescribed a high number of drugs due to co-morbidities. Sensitivity to drugs and 
the susceptibility to side effects lead to increasing numbers of adverse drug reaction-related hospital 
admissions in older patients. Therefore ideally all seniors would receive high-quality pharmaceutical 
care from specialised pharmacists.
In the USA, geriatric certification for pharmacists is a growing trend. The only organization that offers 
a certification in geriatric pharmacy is the Commission for Certification in Geriatric Pharmacy. To 
become designated as a Certified Geriatric Pharmacist, one must be a licensed pharmacist, having 
practised for a minimum of two years, and successfully pass a written examination on geriatric 
pharmacy practice and principles of geriatric drug therapy. The Certified Geriatric Pharmacist (CGP) 
credential is ideal for pharmacists who provide medication management services to older adults. The 
examination is offered internationally and there are CGPs in several countries around the world. In 
USA, training in geriatric pharmacy can be received while enrolled on the PharmD programme. There 
are courses on assessment and pharmacotherapy of older adults and elective modules such as ageing, 
mental health of older adults and medical devices for home health care. In the rest of the world, 
geriatric pharmacy practice teaching is either in the form of a placement in an older people`s ward or 
as an optional course to help students develop specialist knowledge and skills in geriatric pharmacy 
practice. Education with a focus on geriatric pharmacy practice should be standardised to provide a 
uniform pharmacy service to older people globally.
10
Neurological and psychiatric disease 
Professor Alex Thomson, UCL School 
of Pharmacy
Neurological and psychiatric disease 
present enormous challenges to the 
economy in general and to health and 
social service provision in particular. Many 
difficulties are encountered in attempts 
to provide adequate treatment, not least 
an incomplete understanding of the 
root causes of many of these illnesses 
and why and how available treatments 
work. Since many treatments come with 
unpleasant side effects, the pharmacist 
has a fundamental role in advising and in 
encouraging adherence. In addition, there 
is only limited reliable information about their incidence and prevalence, especially in the developing 
world and whether frequently encountered comorbidities are cause, effect, or arise, independently, 
from a common cause. Environmental factors, e.g. pollutants like pesticides and exposure to metals 
like manganese, which contribute to oxidative stress, also appear to play a significant role in, for 
example, the etiology of Parkinson’s disease.
Gene polymorphisms have been linked to the pathogenesis of brain diseases. For some, different 
sites on several different genes are identified as risk factors, though penetrance varies. These 
identified familial risk factors do not yet explain the majority of cases of brain disease, however, and 
the incidence of genetic risk factors and their contributions to disease vary across ethnic groups. 
Predictions of the risk of developing schizophrenia include well established factors like genetic risk/ 
familial history and a reduced incidence (of newly diagnosed disease) with advancing age. In contrast, 
factors for which there is some evidence, such as season of birth, maternal starvation and exposure 
to infections in utero, remain controversial. Etiological evidence suggests that susceptibility to 
Alzheimer’s disease (AD) is controlled genetically, but the precise nature of the underlying risk genes 
and their relation to AD biomarkers remains unclear. As understanding increases, treatments will 
become directed towards patient subgroups requiring pharmacists to become increasingly involved in 
selection of the appropriate treatment.
Expectations that the pharmaceutical industry will make significant progress in the treatment of 
these diseases in the near future have been dulled by the recent closure of many major industrial 
neuroscience programmes. Perhaps particularly distressing is the effect of malnutrition, particularly in 
utero and during the first two years of life, on the risk of complications for cognitive development and 
many other brain diseases. Malnutrition is often exacerbated by intestinal worms, which compete for 
iron and nutrients and cause mucosal damage and inflammation, while poverty encourages the shift 
from nutrient-rich to high calorie, low nutrient foods. More than two billion people worldwide may be 
at risk of iodine deficiency, with the consequent risk of hypothyroid related neurological impairment. 
Salt iodization, adequate intake of energy, protein, and either foods rich in nutrients or dietary 
supplements have contributed to improved mental performance in schoolchildren. The importance of 
the local pharmacist in providing advice matched to local conditions cannot be overstressed.
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Staff perceptions of the relevance of 
global issues to pharmacy education 
and practice
Global issues are not mandatory to the MPharm 
curriculum, and in all cases the inclusion of global 
health topics is dependent on the interests and 
knowledge of individual staff members. This 
reflects the wide range of research concerning 
global health issues conducted by UCL School 
of Pharmacy staff, many of whom are prominent 
researchers in their fields. Those with international 
experience or who are themselves from other 
countries, for instance, are more likely to see global 
issues as relevant to their teaching, regardless of 
their area of expertise. While this kind of exposure 
is certainly valuable for students, its coverage and 
impact on learning are hard to assess and can be 
highly changeable. Such an approach to including 
global topics in the curriculum is also unlikely to 
be sustainable in the long term, especially without 
a supporting framework of agreed learning 
outcomes.
For those staff that, at the time of the research, 
stated that they did not include global issues in 
their teaching, three main reasons emerged. These 
included perceptions of the overall relevance of 
these issues to the everyday practice of pharmacy 
in the UK, concerns about how to incorporate 
them within an already-crowded curriculum, 
and the perception that teaching about global 
issues cannot be easily embedded in teaching 
more ‘technical’ subjects. As one staff member 
commented: ‘I think it is “nice to know” about 
global and development issues but not “need to 
have” because I cannot see how knowing about 
global health inequalities will impact on the daily 
practice of a pharmacist’. Similarly, many staff 
members argued that the crowded nature of the 
MPharm curriculum means that priority should 
be given to material that is perceived to be more 
relevant to the practice of pharmacy in the UK.
Despite such concerns, discussions with staff 
members also highlighted that there was very 
positive support for the need to address global 
and development issues within the undergraduate 
curriculum. Many noted, for instance, that a 
significant proportion of the School’s students 
come from countries other than the UK (in 2012, 
these constituted approximately 25% of the 
student population). Since international students 
are likely to go back to their home countries 
to practise the profession, they will need the 
knowledge and skills to deal with global health 
issues. Moreover, a significant proportion of 
the School’s ‘home’ students come from diverse 
cultural backgrounds, and so bring with them 
different perspectives on health and medicines 
which can enhance their learning.
For some staff, inclusion of global and 
development issues in the curriculum was also 
considered important for the broader and more 
rounded education of pharmacy students. It was 
commented that a role of higher education is to 
motivate individuals to tackle challenging issues. 
Some staff also stated that a pharmacy degree 
should not be limited to producing community or 
hospital pharmacists, but rather it should equip 
students with a broad set of skills and knowledge 
to be able to consider different career paths. 
More broadly, a number of staff members argued 
that pharmacists hold a responsibility as healthcare 
professionals towards global health issues because 
they are not merely technicians, but rather active 
players in healthcare systems that are influenced 
by both national and international factors. As one 
staff member stated: ‘You cannot understand many 
UK health problems without understanding global 
health issues’.
Students’ perceptions of the relevance 
of global issues to pharmacy 
education and practice
Students at the UCL School of Pharmacy were also 
surveyed in order to explore their perspectives on 
the relevance of global issues to their training, as 
well as how and where they thought that those 
issues should be included in the curriculum. 
The sampling was opportunistic and involved 
participants that were being taught by members 
of the project team in 2010 and 2011. In total, 
the survey was conducted with 164 students, of 
which 137 were in their 1st year of study, while the 
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remainder were in the 3rd and 4th years of study. 
As a result, the discussion below is not intended to 
be representative of perspectives from the student 
population as a whole, but nevertheless gives us 
some insight.
The survey showed that most students recognised 
the relevance of global issues to pharmacy 
training, and felt that they should have some level 
of exposure to such issues during the MPharm 
degree programme. In general terms, many 
students felt that this should be part of their 
development as healthcare professionals:
Health issues, e.g. the outbreak of new diseases 
in other countries as well as possible solutions 
should be the concern of all healthcare 
professionals. (1st year student)
It is not uncommon for students to have been 
sheltered their whole lives and not know 
much about the lives of people in developing 
countries since they feel that it may not pertain 
to them. However, exposing them to new 
knowledge can never be a bad thing, and 
can only bring about a positive result, in my 
opinion. (1st year student)
Most students live in a ‘bubble’. It would be 
better to have students that understand how 
education relates to the real world. (1st year 
student)
It is important to learn the issues so we, as 
trained, educated pharmacists, are available to 
help those who need it. (4th year student)
Some students were particularly interested in 
learning about global health issues because they 
planned to work abroad at some point in their 
careers, but there was also limited recognition that 
global issues are relevant to those who planned to 
work only in the UK:
As we have to deal with different people 
(patients) from different backgrounds, this 
would be extremely important. (1st year 
student)
We must be able to provide pharmaceutical 
healthcare to everybody. If we are not 
informed we wouldn’t be able to do this. (1st 
year student)
This recognition of differing perspectives on health 
and medicines may be partly linked to the diverse 
cultural backgrounds, knowledge and experiences 
of the School’s students themselves.
Topics of interest identified by students were wide 
ranging and included new drug development, 
the emergence of new diseases and treatments, 
new drug delivery routes, infections and tropical 
diseases, susceptibility of specific groups to 
particular diseases/ illnesses, global supply chains, 
and personalised formulations, as well as more 
socially-oriented issues such as differing cultural 
beliefs around health and medicines, working 
with diverse patient groups, law and ethics 
related to pharmacy in particular contexts, the 
role of pharmacists in other countries, the work 
of international health organisations and NGOs, 
diverse health systems, access to medicines, 
and challenges to health provision in a range of 
contexts.
However, some students expressed doubts as 
to whether all pharmacy students need to learn 
about global issues, particularly given other 
priorities in the MPharm curriculum:
If it is possible and there’s enough time on 
the course they should learn, but as the 
majority will be practising in the UK, the main 
focus should be UK. Learning about global 
development is important because if we could 
help globally we should make the effort. (1st 
year student)
Many students want to stay and practise in the 
UK so they are less likely to take interest. (4th 
year student)
Students should be given the option to learn 
topics of their own interest. Some might just 
prefer to work in the UK where they won’t need 
this training. (1st year student)
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It’s unfair to force students to learn about 
something that’s not essential to their degree. 
(1st year student)
Still other students saw it as something that all 
students should be introduced to, with more 
focused study reserved for those with a particular 
interest:
Not all students want to go into global and 
development issues. But overall it should be 
taught in the MPharm course so students are 
aware of issues to do with health around the 
world. (1st year student)
I think a general overview should be taught 
to all students - however those students who 
have a specific interest could possibly take this 
as an optional unit where the subject goes into 
depth. (1st year student)
Some students may not have any idea what it is 
about until they are taught. (4th year student)
Conclusions of the initial research
In summary, the surveys and interviews 
demonstrated a general positive trend in the 
views of both students and teaching staff towards 
the importance of learning about global health. 
However, a major concern amongst teaching 
staff at the School was about how teaching and 
learning about global topics can be incorporated 
into an already-packed curriculum. One way of 
addressing this concern is to embed global topics 
within existing taught sessions, for instance by 
reorienting the ways in which material is taught 
(e.g. by including international case studies), 
rather than adding a large block of new teaching. 
Embedding global issues throughout the 
curriculum in this way can also have the added 
benefit of reaching all students, rather than just 
those with an existing interest. The findings of this 
research led to the development of a set of draft 
Global Pharmacy Learning Outcomes for inclusion 
in the core curriculum (see pg. 20) which have the 
potential to support these efforts.
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Medicines from natural products, 
sustainability and intellectual property 
rights 
Dr. Sarah Edwards,  
UCL School of Pharmacy
With the world’s increasing human 
population, now more than 7 billion, 
pressure on the natural resources on which 
we all depend has never been greater. 
The impact of humanity on planet Earth 
is so profound, that it has initiated a new 
geological epoch, the Anthropocene. 
Species extinction rates are currently 
estimated at 100-1000 higher than 
background rates, being on a par with 
the five catastrophic mass extinctions of 
geological history. Why is this of significance to pharmacists?
• In some developing countries, 80% of the population are dependent on traditional medicine for 
their primary healthcare, in which medicinal and aromatic plants (MAPs) play a significant role.
• OTC herbal medicines are also increasingly popular in the developed world, with about half a 
million tonnes of raw material sold every year on the global marketplace.
• The majority of traded herbal medicines are from wild harvested plants, which makes 
misidentification more likely and the possibility of unwanted plant material being included
• Collection of medicinal plants is unregulated in many countries and unsustainable collection 
practices are confounded by the low wages that many harvesters receive, which may be the only 
source of paid employment in some rural areas.
• This is a health issue as well as an environmental and socio-economic one, as the rarity of 
MAPs is likely to lead to inferior quality products on the market, which may contain harmful 
adulterants or substitutions.
• Many of the world’s pharmaceutical medicines are also based on natural products: 68% of 
anti-infectives (anti-bacterial, -fungal, -parasitic and –viral) that came to market in the 30 years 
between 1981 and 2010 are naturally derived or inspired; and 48.6% of all new anti-cancer drugs 
since the 1940s are either natural products or directly derived from them.
‘Bioprospecting’ for novel compounds from natural sources has not been without controversy. A few 
high profile cases in the last 20 years have highlighted the misappropriation of traditional medicinal 
knowledge (‘biopiracy’), without compensation and acknowledgement for the traditional knowledge 
holders and their intellectual property (e.g. the issue of a US patent on the use of turmeric as a wound 
healer). International agreements, including the World Trade Organisation’s Trade-Related Aspects of 
Intellectual Property Rights (TRIPS), which sets global standards on the protection and enforcement of 
intellectual property rights, and the Convention on Biological Diversity, which addresses the acquisition 
and use of biological material and related information, have changed the nature of natural product 
research.  Access and benefit sharing agreements are now a prerequisite, and national legislation (e.g. 
in Brazil) may prohibit scientists from collecting biological material without difficult-to-obtain permits.
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In the course of the project, several new teaching 
and learning activities were piloted, with a view to 
exploring their feasibility for future use within the 
MPharm programme and UCL School of Pharmacy 
more widely. This included an introductory lecture 
and student poster project in the first year of the 
MPharm, the creation of a ‘Global Awareness’ 
resource pack for use in tutorial sessions with first 
year students, visits by external speakers, and an 
interdisciplinary workshop with students from UCL 
School of Pharmacy, UCL Medical School and the 
Royal Veterinary College.
Lecture, poster preparation and in-
class activity with first year MPharm 
students
In their first week of the degree course, first 
year MPharm students participated in a 1-hour 
session entitled ‘The Global Pharmacist’.  The aim 
of the session was to engage the students with 
issues related to global health. Using pictures 
and scenarios (such as the swine flu pandemic, 
a world map showing the locations of extreme 
drug-resistant tuberculosis, a patient with leprosy, 
a table giving examples of reported incidences 
of counterfeit medicines, and scientists studying 
plants in Kenya) the students were led into a 
discussion of global issues. These included the 
global nature of many diseases and their speed 
and mode of spread; the use and abuse of 
antibiotics; the influence of different government 
agencies and the spread of antibiotic resistance; 
old, neglected and poverty-related diseases which 
have still not been eradicated; drug donation by 
manufacturers, the latter’s location and main drug 
targets; the international problems of substandard 
and counterfeit medicines; and the rights of 
societies to their traditional medicinal knowledge, 
among others. 
The session was used to engender critical thought 
about global health issues, and to lead to the 
realisation of the inter-connectedness of the 
world, and of the pharmacist’s role in reducing 
the burden of disease and associated causes and 
consequences. Questions from students led to 
further discussion about children’s health and 
the role of UNICEF, eradication of smallpox, and 
possible job opportunities with organisations such 
as Pharmaciens Sans Frontières.
In addition to the session described above, the 
first year students also participated in an optional 
session where they made posters entitled 
‘Pharmacy in My Country’. Students from countries 
including Malaysia, Vietnam, and Sudan took part. 
While one student contacted a Minister who sent 
him a presentation with lots of information about 
healthcare in Malaysia, another spent many hours 
outside the scheduled session to produce a very 
creative poster about healthcare in Vietnam. The 
session also allowed some discussion of sensitive 
issues such as poverty and its consequences, such 
as criminal activities.  Due to the voluntary nature 
of the poster session and other factors, such as 
unfavourable timetabling, the poster session was 
not well attended.  Consequently, the following 
year, the optional poster session was replaced 
by an in-class activity during the first Global 
Pharmacy lecture to the new MPharm students. 
The latter were asked to write about their last 
visit to a pharmacy (and whether this was in their 
country of origin), their impressions of it (positive 
and negative), and ways in which the practice of 
pharmacy might be improved. The aim was to 
encourage the students to reflect on and relate 
their experiences to their studies, and to start the 
students thinking about pharmacy settings and 
practices in different countries. 
Global Awareness resource pack 
A ‘Global Awareness’ resource pack was also 
created and distributed to academic tutors to use 
in tutorial sessions with first year students. The 
pack included a range of suggested readings and 
sample activities that could be used to encourage 
students to explore the complex nature of global 
health issues and to consider their role as global 
professionals. This included a map of the world to 
initiate discussions of how the lives, priorities and 
New Teaching and Learning Activities
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health of people in different parts of the world 
may differ, as well as graphs and charts illustrating 
changing patterns of disease to stimulate debate 
around wide-ranging political, social and cultural 
factors that may influence availability and use of 
medicines.
Many of the lecturers interviewed for the project 
also welcomed the idea of making global health 
issues the theme for journal club sessions which 
are run in the fourth year. In these sessions, 
each student presents two journal articles to a 
small group of students and the articles are then 
discussed amongst the group. As with the first year 
tutorials, these sessions would provide students 
with an opportunity to discuss the broader 
role of pharmacy professionals in addressing 
global health concerns with their peers and with 
guidance from tutors.
Visits by external speakers
External speakers are regularly invited to talk 
about their experiences overseas. One example is a 
contribution by Rocio Villacorta-Linaza, a qualified 
pharmacist who spent several years working in 
Pakistan, Afghanistan, South Sudan and Algeria 
for NGOs such as Merlin, Médecins Sans Frontières 
and Medico International. The seminar was open to 
all students and staff from the School. The session 
highlighted particular problems of maintaining 
supplies of medicines relevant to the needs 
of local communities in countries in crisis. The 
identification and operation of systems for supply 
in these situations were discussed. In particular, 
the session emphasised the unique value of 
pharmacists in undertaking such a role.
This seminar provided students with an 
opportunity to learn how pharmacy training can 
be put to use as part of a diverse career path and 
the potential routes to such a career. Exposure to 
these ideas is important, given that many of our 
students see their career trajectory as involving 
work only in a UK-based clinical setting. Other 
potential career paths could involve, for instance, 
work for non-governmental or international 
health organisations such as the WHO, Médecins 
Sans Frontières, or Pharmaciens Sans Frontières, 
or in research and advocacy organisations. 
Subsequently, Médecins Sans Frontières was 
invited to take part in the School’s Career Fair, 
and interested students learned about the 
requirements of working with international health 
charities, such as the need for a few years’ work 
experience and proficiency in a second language.
These visits and events have been particularly 
valuable as there is no obvious career path for 
students with these interests and they will be 
pioneers in pursuing new roles.
Interdisciplinary workshop with 
students from UCL School of 
Pharmacy, UCL Medical School and 
the Royal Veterinary College
In partnership with the UCL Institute for Global 
Health, the Royal Veterinary College and the 
Institute of Education, the project team at 
UCL School of Pharmacy also organised two 
interdisciplinary workshops on Avian Influenza for 
students from all three colleges. The objectives of 
the sessions were to provide pharmacy, medical 
and veterinary students with the opportunity 
through role play to: (i) have an increased 
appreciation of the complex nature of global 
health concerns, and particularly zoonotic disease 
outbreaks, and (ii) develop an understanding 
of the need for, and challenges associated with, 
collaboration between health professionals 
and between actors and organisations at local, 
national, regional and international levels.
Students were presented with an outbreak 
scenario in South Sudan and then divided into 
interdisciplinary groups representing key national 
and international interests that respond to 
pandemics: local health professionals, officials 
from the Ministry of Health and Ministry of 
Animal Resources in Sudan, representatives 
from international health organisations (e.g. 
WHO, Food and Agriculture Organization, World 
Organization for Animal Health), multinational 
pharmaceutical industry representatives, and local 
and international media organisations. Within each 
group, the players were instructed to discuss the 
response they would make to the scenario and the 
questions this raised in terms of both human and 
animal health. At various points in the workshop, 
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Pharmaciens Sans Frontières (Pharmacists Without Borders)
Pharmaciens Sans Frontiers (PSF) was founded by pharmacists in 1985, in Clermont-Ferrand, France, 
and today has branches in a number of other countries such as Switzerland, Canada, Germany, 
Denmark, and Sweden. Its aim is to promote access to quality health care and medicines by all 
populations, and it has worked in many underprivileged parts of the world. PSF has raised awareness 
about the pharmacist’s critical role in public health, good pharmaceutical practice, rational prescribing, 
and correct use of medicines. Its initiatives and operations include the construction of healthcare 
infrastructure, training the associated local personnel, activities to increase awareness about the 
dangers of street medicines and for the prevention of HIV/AIDS, and promotion of access to healthcare 
by vulnerable and isolated populations. PSF also organises meetings, such as the forum ‘Pansons le 
Monde’ (Heal/Bandage the World), and a round-table discussion to contribute to the strengthening of a 
regional strategy for the fight against falsified medicines in West Africa.  
PSF campaigns and educates, for example, against the donation of unused patient medicines to poorer 
countries. According to PSF, unused patient medicines are not appropriate for donation for a number 
of reasons, including the inability to guarantee their quality, the fact that they do not enter inventories 
or the official medicine distribution channels, and they can participate in the development of illicit 
markets for medicines, which has a huge detrimental effect on public health and on the economic 
development of affected countries. In addition, PSF has noted on the ground that such donated 
medicines are not appropriate for the diseases prevalent in the recipient countries, are unknown to 
local health professionals, often arrive out of date and the accompanying information is in a language 
that is unknown or poorly understood locally. Furthermore, local populations become accustomed to 
expensive medicines, which short-circuit the official pharmaceutical channels and compete with the 
local economy.
the groups were also asked to ‘negotiate’ about 
their planned activities with other relevant groups, 
such as asking for greater financial assistance. 
At the end of the session,  the whole group was 
brought back together for discussion and debate.
These interdisciplinary workshops were a 
particularly successful component of the project. 
Student feedback was overwhelmingly positive, 
with participants recognising the importance of 
working with other health professionals and the 
value in a multi-levelled approach to complex 
global health concerns:
It is important for people from different 
disciplines to come together to work on issues, 
as each has different knowledge experiences 
and can contribute from different perspectives. 
Pharmacy student
It is important, especially for medical students, 
to leave our insular ‘bubble’ once in a while 
and see the wider political, professional and 
international aspects of medical issues.  
Medical student
It is important to realise how global issues 
regarding animals and humans are dealt with 
on a large scale (not just at the ‘farm level’). 
Veterinary student
The teaching and learning activities that 
developed during the project provide models of 
new opportunities for the School’s students to 
actively engage with international issues. They also 
introduced students to global and interdisciplinary 
perspectives that they might not otherwise 
have encountered as part of the core pharmacy 
curriculum.
18
Pharmacy education in Namibia 
Dr Tim Rennie, Head of Department of 
Pharmacy, 
University of Namibia and UCL School 
of Pharmacy Alumnus
I report from Namibia as a registered UK-
trained Namibian pharmacist helping to set 
up the first Namibian School of Pharmacy 
in the country. Namibia is a newly 
independent, southern-African country 
with disease burden as you would expect – 
HIV/AIDS, TB and to a lesser extent malaria. 
However, there is also a burgeoning 
non-communicable disease burden and in 
this sense is characteristic of a developing 
setting with upper-middle income country 
status – something of a paradox. Namibia is the second least densely populated country with the 
highest degree of inequality as measured by the Gini index. The economy is driven by three main 
factors: mining, agriculture (particularly livestock) and tourism. Hence, the challenges as well as the 
opportunities compared to the UK are very different.
In the Pharmacy setting – and the reason a new School of Pharmacy has been established – there is 
a serious shortage of pharmacists both in the public and private sectors; the aim is to roughly double 
the current numbers. However, the landscape in the pharmacy profession is relatively well organised 
with all the major pieces of the puzzle in place – a medicines regulator and a professional regulator 
enacted by Parliament, a strong community sector and a developing public sector, pharmacy support 
staff training, professional regulation, healthy wholesale and supply chain, quality surveillance in 
terms of medicines quality and pharmacovigilance, and now tertiary pharmacy education. However, 
currently, there is a distinct lack of research and publication in pharmacy and approximately 99.9% of 
medicines are imported from outside Namibia.
This specific setting has dictated the way in which the Bachelor of Pharmacy (Honours) degree 
curriculum was articulated and is now being operationalised. A needs-based approach was applied 
in defining exit level competencies from which the curriculum has developed through a six-stage 
approach. This has sought to address the challenges of Pharmacy in Namibia through the future 
pharmacists it will produce. A graduate pharmacist will need to be a generalist as the likelihood of 
practising in, for example, regulatory pharmacy, policy development or veterinary pharmacy, are 
relatively high compared with the UK setting where the number of graduates are far greater and 
the majority will practice in community or hospital pharmacy sectors. In addition, there is a heavy 
emphasis on research as well as pharmaceutics as we try to gear up the future pharmacists to develop 
research and industry. The students undertake four 1-month placements (rural, hospital, community, 
manufacturing/industry) as part of their curriculum to prepare them for their one-year internship that 
could be as broad.
In summary, what defines a pharmacist more than anything is their expertise in medicines, wherever 
they may practise. However, the application of the knowledge, skills and attitudes – as well as an 
appreciation of the finer details such as law, cultural practices and future needs – can result in a very 
different practice from setting to setting.
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It is important to note that the teaching activities 
described above took place as a result of the 
enthusiasm and energy of individual staff 
members at the UCL School of Pharmacy; these 
and similar activities have yet to be integrated 
formally into the MPharm curriculum. In an effort 
to begin developing more formal structures to 
support learning about global issues, a draft set 
of Global Pharmacy Learning Outcomes was 
devised in discussions with academic staff from all 
disciplines of pharmacy4.1
Global health education for pharmacy students 
can be divided into two categories: compulsory 
teaching to prepare all pharmacists for practice 
or optional teaching for undergraduates with a 
special interest in global health, some of whom 
may plan to work overseas. The global pharmacy 
learning outcomes proposed here are for core 
teaching, and are intended to prepare all pharmacy 
4 Similar sets of learning outcomes have also been 
drafted for medicine (Johnson et al 2012) and veterinary 
medicine (Maud et al 2012).
Learning Outcomes for Global Pharmacy
graduates to become globally-aware professionals 
– regardless of where in the world they intend to 
work. The outcomes focus on pharmacy education 
in the UK, but may also provide examples and 
stimulate debate for other disciplines and in other 
countries.
It is intended that the learning outcomes will 
be achieved through core teaching throughout 
the MPharm degree programme. There will be 
‘horizontal integration’ focusing on international 
issues relevant across different subject areas within 
each year of study, as well as ‘vertical integration’ 
in which more complex international contexts 
are introduced as students progress through the 
4-year programme. The learning outcomes have 
been organised into 6 domains: public health and 
chronic disease; political, economic, social and 
cultural dimensions of medicines and pharmacy; 
pharmaceuticals; international infrastructure for 
supply and use of medicines; professionalism; and 
interdisciplinary factors and their relevance to 
health, medicines and pharmacy.
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Public health and chronic disease
• Explain changes in patterns of disease and their impact on international health priorities
• Identify current priorities and the potential for pharmacy to support public health goals
• Discuss concepts of and approaches to health promotion and prevention of ill health 
from an international and inter-sectoral perspective
Political, economic, social and cultural dimensions of medicines and 
pharmacy
• Understand the importance of access to, and the rational use of, medicines in the global 
context
• Recognise the existence of inequalities / inequity in provision and access to medicines 
both in the UK and around the world
• Demonstrate awareness of the costs and resource implications of global pharmaceutical 
provision
• Discuss the relevance of the cultural context to the use of medicines 
• Recognise the impacts of fragile states and crisis situations (e.g. armed conflict, natural 
disasters, trade embargoes) on pharmaceutical care
Pharmaceuticals
• Describe the different pharmaceutical treatments available to, and affecting the health 
of the world’s population, including that of the ‘bottom billion’
• Recognise the need for, and identify the priorities regarding the development of 
pharmaceutical products that are suitable for different population groups (such as 
younger and older people) and sensitive to cultural preferences
• Identify how pharmaceutical science can be applied to formulate medicines and 
vaccines that are suitable for diverse environments and climates
• Explain the role of ‘personalised medicine’ in the context of global pharmacy
Draft Global Pharmacy Learning Outcomes
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International infrastructure for the supply and use of medicines
• Identify diverse international models of health care systems and provision, and explain 
how these impact on pharmacy services and medicines supply and use
• Discuss current concerns regarding the pharmacy workforce for international health 
and pharmaceutical care
• Demonstrate awareness of the challenges of ensuring universal supply of quality 
medicines
• Summarise the challenges associated with international regulation to ensure the safe 
use of pharmaceutical products, including those that can be used recreationally
Professionalism
• Identify relevant UK and international codes of ethics for pharmacists
• Respect the rights and equal value of all people without discrimination and provide 
compassionate care for all
• Recognise that relationships with other health practitioners, and working effectively 
with colleagues from diverse backgrounds, is crucial to optimise pharmaceutical care
Interdisciplinarity in health, medicines and pharmacy
• Recognise the role of poverty and inequality in health, and implications for medicines 
and pharmacy 
• Describe how climate change and health interact at local and global levels
• Discuss the links between globalisation, food security, dietary transitions and health
• Describe the influence of biocultural diversity and environmental change on health, 
medicines and pharmacy
• Identify the links between human and animal health, particularly in terms of use of 
medicines
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The Students as Global Citizens project explored 
a variety of methods for including global topics 
in the undergraduate curriculum. Based on the 
experiences of the project and a growing body of 
educational research, further ideas for embedding 
global awareness within the programme include 
more interdisciplinary and inter-professional 
collaboration, and the development of 
international partnerships, peer mentoring and 




One of the key successes of the project was the 
development of the interdisciplinary workshops 
on Avian Influenza for students from the three 
partner colleges. In addition to providing a rare 
opportunity for students in the three professions 
to interact, these workshops also reflected one of 
the wider aims of the Students as Global Citizens 
project – to encourage healthcare students 
to recognise the need for interdisciplinary 
approaches in order to address the multifaceted 
challenges of global health. Student feedback 
after the events revealed that the vast majority of 
participants would welcome further opportunities 
to take part in interdisciplinary teaching and 
learning activities, including interactive events 
and workshops as well as collaborative research 
projects.
Organising these workshops can be logistically 
challenging. It requires participating institutions to 
identify available spaces in their busy timetables. 
Workshop discussion also works most effectively 
with relatively small groups of students (around 
30), which imposes limits on how many students 
can take part. Nevertheless, it may be possible to 
design a series of inter-professional workshops 
over the course of each academic year that would 
provide more occasions for a greater number 
of students to explore global health issues from 
different perspectives. It is also important for 
higher education institutions to find ways of 
making these kinds of teaching and learning 
activities more sustainable, for instance, by linking 
them to learning outcomes and formal structures 
of assessment.
International partnerships
The MPharm programme at UCL School of 
Pharmacy provides opportunities for students 
to study abroad during their third year of study. 
The School takes part in the Socrates-Erasmus 
Programme which offers student exchanges 
with 30 universities in 13 countries (North 
America, Australia and Europe). This possibility of 
international study is one of the features of the 
School’s curriculum that is most commonly noted 
and welcomed by prospective students during 
recruitment events. Extending these exchange 
programmes to universities in middle and low-
income countries may enable mutual learning 
and collaboration to the benefit of both students 
and staff in UK and overseas institutions.  MPharm 
students could also be encouraged to exploit their 
membership of BPSA, EPSA, IPSF and FIP to create 
student-exchange opportunities.
Partnerships with other international health 
organisations  supporting global health can also 
enable students to gain insights into different 
settings, circumstances and priorities in health as 
well as see the diversity in professional practice 
and potential career opportunities which are 
available to them once qualified. 
Future Opportunities for Embedding Global Issues in the
MPharm Curriculum
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Vulture mortality in India: An 
ecotoxicology case study 
Professor Richard Kock 
Royal Veterinary College, London
Cows throughout South Asia are often 
treated with diclofenac, a drug formulated 
for both veterinary and human use that 
reduces pain and inflammation. This drug 
is lethal to vultures that ingest both human 
(Parsee communities traditionally allowed 
scavengers to dispose of human carcasses) 
and animal carcasses after death. This 
problem has been exacerbated by the 
veneration of the cow into old age when 
large quantities of this drug, which is cheap 
and accessible, are administered to relieve 
discomfort up until death. The cows after 
death decompose in the environment or are scavenged.
Vultures, animals that have been reviled and revered throughout time, serve a highly valuable 
ecological role through the removal of dead carcasses of animals and thus contribute to the 
maintenance of public health (preventing the spread of disease agents) and the health of the 
ecosystem. From 1992-2007 several species of vultures experienced serious and rapid declines 
throughout Asia. It was found that experimentally, vultures ingesting cattle carcasses that were recently 
treated with diclofenac needed very little of the drug to succumb to kidney failure and eventual death. 
Diclofenac residues in the tissues of dead cattle are highly toxic to vultures, resulting in up to 99% 
mortality. The near extinction of several species of vultures was met with a resounding response from 
conservation. Drug manufacturing companies have also responded in kind by increasing production 
of the alternative anti-inflammatory drug meloxicam. While national and local governments banned 
veterinary use of the drug in 2006, unfortunately, continued use of the human equivalent has persisted.
A significant issue, that this story brings to light, is that research and development for pharmaceuticals 
does not take into account ecotoxicological risk of new products to birds (and many other species). 
There is an internationally agreed protocol for licensing of human drugs, which involves a series of 
drug evaluation trials starting from primitive organisms like daphnia to highly evolved vertebrates, 
like primates and finally on humans. Although the industry is sympathetic to the problem of failure to 
identify environmental risk, there is no legislative framework to reduce this risk. The cost of altering 
testing protocols to make them environmentally safe is considered prohibitive and discourages a 
voluntary change. Bringing a new drug to the market costs 100s of millions of pounds and the window 
for recovering investment is 10 years for the inventors. After this time the drugs are copied and generic 
products proliferate, making it virtually impossible after this time to recall. This was the case with 
diclofenac. The cause of the vulture mortality was only discovered after 15 years or so of the drug’s use 
on the market. Long after it was a generic. With current laws focused on human safety, and ignoring 
human pharmaceutical impacts on biodiversity, little can be done to combat this devastation. Removal 
of the veterinary products from the market have not proven to be enough as farmers continue to use 
the human product on their animals, showing how important it is that there is greater integration of 
the human and veterinary health sectors to tackle these sorts of issues.
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Peer mentoring
UCL School of Pharmacy’s student body comprises 
a significant international population, including 
international postgraduate students in MSc 
programmes and doctoral study, who are well-
placed to share their expertise and provide 
peer mentoring for undergraduate students. 
Postgraduate students have provided significant 
support for the Students as Global Citizens 
project. For example, doctoral students were key 
collaborators in the development and facilitation 
of the Avian Influenza workshop mentioned 
above. In the future, postgraduate students 
could also share their knowledge and expertise 
through workshops, discussion groups, or one-
to-one mentoring sessions, providing MPharm 
undergraduate students with the chance to 
interact with and learn about diverse international 
contexts of pharmacy practice and research.
In addition, the School’s ‘home student’ 
population often includes a considerable number 
of individuals who are 1st, 2nd, 3rd generation 
migrants to the UK. This diverse cultural heritage 
provides a rich source of different backgrounds, 
experiences and perspectives on health that 
could make a significant contribution to 
discussions of global pharmacy. Through both 
formal sessions and informal discussion, students 
should be encouraged to reflect on this cultural 
knowledge and to appreciate its value to their 
professional practice, particularly in terms of their 
understanding of health and medicines, and their 
ability to work sensitively with diverse patient 
populations.
Students with experience of international study 
or work can also encourage fellow students’ 
involvement in tackling and learning about 
global and development issues through a range 
of activities such as peer mentoring schemes or 
presentations and reports about their experiences. 
They could also provide support to undergraduate 
students who would like to study or work overseas, 
but who may find it challenging to identify 
ways of getting involved in international work, 
particularly in terms of finding a host organisation 
and arranging funding. An online database of 
projects and research reports could be created to 
showcase the international work of the School’s 
staff, undergraduate and postgraduate students, 
and to provide interested students with contacts 
for information and advice.
The School also has a number of visiting 
undergraduate pharmacy students from different 
universities, under the auspices of the Socrates-
Erasmus Programme. These visiting students 
come to the School to conduct their research 
projects, and thus usually interact mainly with 
their laboratory colleagues and with other visiting 
students. Despite the fact that they have much in 
common, opportunities for interactions amongst 
the School’s MPharm students and visiting 
pharmacy undergraduates are few. Events to 
bring the two student bodies together to increase 
interactions could be organised. For example, 
visiting and home students could give short 
presentations about their degree programmes, 
allowing the visitors to integrate more deeply into 
the School and for home students’ knowledge 
about other pharmacy education systems and 
practices to be enhanced.  This could also inform 
and encourage more of our home students to 
conduct their research projects abroad. 
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Mr Anthony Ajose, MPharm,  
UCL School of Pharmacy Alumnus
Following the MPharm degree at the UCL 
School of Pharmacy, I undertook split 
Primary Care Trust (PCT) and hospital pre-
registration placements, gaining experience 
in public health, medicines management 
as well as in clinical pharmacy; this 
complemented the theoretical experience 
gained from the pharmacy degree. 
Following my growing interest in public 
health, I then undertook an MSc in Public 
Health and Health Economics at the London 
School of Hygiene and Tropical Medicine. 
During this programme, I carried out an 
internship with the health economics 
team at Sanofi and carried out an economic evaluation of HIV prevention interventions for the Gates 
Foundation Avahan programme in India for the MSc project. I then embarked on research positions 
at the WHO in Geneva, working in the Patient Safety Information (PSP) and Essential Medicines and 
Pharmaceuticals policies (EMP) departments on capacity development projects.
I currently work in the field of market access and evidence based medicine, providing strategy-
consulting services for the life sciences industry. In my spare time, I participate on medical missions, 
working as part of an allied health team, providing much needed medical services to people with little 
access to formal healthcare across countries in developing countries. I intend on becoming more active 
in the provision of high quality health services to these regions in the future.
Student-led societies and 
organisations
As the surveys conducted during the project show, 
undergraduate students have a significant interest 
in learning and engaging with global health 
and pharmacy issues. Although UCL School of 
Pharmacy has a number of student-led societies, 
none has an explicit interest in global health. A 
new society might be formed at the School, or in 
coordination with an existing student organisation 
(e.g. the BPSA, EPSA or IPSF).
There are also a range of existing organisations 
in which pharmacy students could be involved. 
The BPSA has an ‘International Pharmacy’ page 
on its website, and as noted in the introduction, 
membership of the BPSA automatically provides 
membership to both the EPSA and IPSF. Pharmacy 
students can also usefully collaborate with other 
student health professionals interested in global 
health concerns, for instance, through membership 
in Medsin, which is actively involved in tackling 
global and local health inequalities through 
education, advocacy and community action5.1
5 See www.medsin.org 
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The Treatment of Visceral 
Leishmaniasis 
Dr. Abeer Mohamed Ahmed 
UCL School of Pharmacy
I am a pharmaceutical scientist. My 
PhD research was focused on the 
development of a stable, safe and cost 
effective pharmaceutical formulation 
of amphotericin B for the treatment of 
visceral leishmaniasis.
Visceral leishmaniasis (VL) is a parasitic 
infection which is considered a neglected 
disease and is endemic in resource 
limited regions of the world. It is fatal 
if untreated. Amphotericin B (AmB) is 
widely used for the treatment of systemic 
fungal infections. It is also effective against VL. Unfortunately AmB is very toxic and requires careful and 
repeated administrations over a 28-day period to VL patients. The best AmB formulation, AmBisome® 
(liposomal AmB) is too expensive and unstable for widespread use of a neglected disease in resource-
poor settings.
Thus, my project aim was to prepare a stable, easy to sterilise, and non-toxic intravenous formulation 
of AmB that has similar activity as AmBisome®. I achieved this, and developed a formulation which 
essentially consists of a non-covalent association between AmB and poly(glutamic acid) (PGA). PGA is 
a biodegradable and biocompatible polymer that has been evaluated clinically. The polymer is used 
as a lipid replacement to produce vesicles of similar size and charge as are present in AmBisome®. The 
AmB-PGA complex was found to have an equivalent dose response to AmBisome® in an acute model 
of VL in vivo. This AmB-PGA complex is much more stable than AmBisome®. The project is now being 
funded by the charity, Drugs for Neglected Diseases Initiative and efforts are underway to develop this 
formulation in India where leishmaniasis is a major problem. Analysis of both the cost of goods and 
cost of manufacture suggest that if this formulation can be developed, the cost of the final dosage 
form will be about 10% of that of AmBisome®.
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FIP Key Messages for the Global 
Student Project 
Professor Ian Bates, Director, FIP 
Education Development, 
UCL School of Pharmacy
The International Pharmaceutical 
Federation (FIP), as the global 
professional leader, ensures that 
education and training provides the 
foundation for pharmaceutical services 
and professional development and 
advancement, in order to meet global 
societal needs for medicines expertise. 
FIP represents over 3 million pharmacy 
healthcare workers from 127 countries 
worldwide.
Access to good quality medicines and competent and capable healthcare professionals are 
fundamental aspects of any healthcare system; uninterrupted supply of quality medicines to the 
population, their management, and responsible use, are vital components in improving the health of 
nations. However, pharmacy workforce per capita varies considerably between countries and WHO 
regions and generally correlates with country level economic development indicators.  Countries 
and territories with lower economic indicators, such as those in Africa, tend to have relatively fewer 
pharmacists and pharmacy support workers. This has implications for observed inequalities in access 
to medicines and medicines expertise.
Strategic frameworks and policies related to the pharmacy workforce are being successfully developed 
and implemented at the country-level through multi-stakeholder processes involving ministries 
of health, health professional associations, regulators and educators, to drive and achieve both 
competence and practitioner excellence for care quality. We should share and adopt these best 
practices through the application of leadership values and partnership working across the globe.
Investment in transforming and scaling up professional education is crucial, as education provides 
the foundation for building a capable healthcare workforce. The capacity to provide pharmaceutical 
services in each country is dependent upon having an assured competent workforce and a similarly 
integrated academic workforce to train sufficient numbers of new pharmacists and other support 
staff at both foundation and advanced levels. On-going effort is needed to ensure capacity building of 
skilled medicines expertise to meet the pharmaceutical health needs of populations.
FIP advocates for a needs-based education strategy that will allow local systems to best assess the 
needs of its community and then develop (or adapt) the supporting educational system in order to 
produce a workforce relevant to these needs. National healthcare demands are diverse and complex, 
often varying widely within and between regions. Although broad and general frameworks may be 
beneficial at the macro level, a “one-size-fits-all” system does not offer the authenticity needed for full 
engagement and sustainability at the domestic level. Pharmaceutical Human Resources continue to 
be a priority issue for FIP Education initiatives (FIPEd) in order to engage in a collaborative way with 
all stakeholders; we need to work towards developing a profession that can meet present and future 
societal and pharmaceutical health needs around the world.
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Conclusions
Global issues, including development priorities, 
cross international boundaries and encompass 
different governmental sectors, disciplines, types 
of organisation and activities. Good health is not 
only a result of, but also a condition for, socio-
economic development, security, and human 
rights. It is fundamental to the quality of life 
and well-being of people everywhere. In terms 
of health needs, medicines use and pharmacy 
practice, there is much that is common between 
countries, especially regionally. However, there is 
also much that is diverse both between countries 
and between population groups within any 
country. Access to, and ensuring appropriate use 
of, medicines is central to the professional roles of 
pharmacists. 
The work of this project highlighted that UCL 
School of Pharmacy students are already exposed 
to a wide range of international issues and 
perspectives throughout their studies. However, 
this relied on the initiatives and expertise of 
interested teachers, as global pharmacy is not 
a core part of the MPharm curriculum. There is 
therefore a need to embed global pharmacy 
within the core curriculum in order to ensure 
sustainability and so that all pharmacy students are 
prepared to a greater extent for the various roles 
they could play as pharmacists in an increasingly 
globalising world. This led to the development of 
a draft set of Global Pharmacy Learning Outcomes 
for pharmacy students in the UK which are 
intended to stimulate the on-going integration of 
the global dimension within pharmacy education.
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